Study of a new heart health medicine in healthy adults
Part of Hormones & metabolism clinical trials.
This study tests a new medicine for heart health in healthy volunteers. It aims to see how the body handles the medicine when taken alone or with another medicine, and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your blood pressure must be in a normal range (not too high, not too low).
- Your body mass index (BMI) must be between 18.5 and 35.
- You must have a certain level of LDL (bad cholesterol) in your blood.
- You must be in good general health with no ongoing medical conditions.
- If you are a woman who can become pregnant, you must use two reliable forms of birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called CG-0416 in healthy volunteers to see how safe it is and how the body handles it. The drug is given as a single dose or repeated doses, and researchers will monitor your health and cholesterol levels.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests a new medicine in healthy people to see how it is absorbed and broken down by the body, and to make sure it is safe. If you join, you will take the medicine under fasting conditions and have regular blood tests.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.
Hear when a new Otherwise Healthy Individuals With Systolic Blood Pressure (SBP) From 110 to 139 mmHg and Low-density Lipoprotein Cholesterol (LDL-C) ≥ 100 mg/dL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.